Follow
Loganathan Rangasamy
Loganathan Rangasamy
Associate Professor, DBT Ramalingaswami Re-entry Fellow
Verified email at vit.ac.in
Title
Cited by
Cited by
Year
Mixed Ligand Copper(II) Complexes of N,N-Bis(benzimidazol-2-ylmethyl)amine (BBA) with Diimine Co-Ligands: Efficient Chemical Nuclease and Protease …
R Loganathan, S Ramakrishnan, E Suresh, A Riyasdeen, MA Akbarsha, ...
Inorganic chemistry 51 (10), 5512-5532, 2012
2312012
New ruthenium (II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and …
M Ganeshpandian, R Loganathan, E Suresh, A Riyasdeen, MA Akbarsha, ...
Dalton Transactions 43 (3), 1203-1219, 2014
2002014
Interaction of mixed ligand copper (II) complexes with CT DNA and BSA: Effect of primary ligand hydrophobicity on DNA and protein binding and cleavage and anticancer activities
M Ganeshpandian, R Loganathan, S Ramakrishnan, A Riyasdeen, ...
Polyhedron 52, 924-938, 2013
1142013
Copper (II) complexes with 2NO and 3N donor ligands: synthesis, structures and chemical nuclease and anticancer activities
C Rajarajeswari, R Loganathan, M Palaniandavar, E Suresh, ...
Dalton Transactions 42 (23), 8347-8363, 2013
1112013
Mixed ligand μ-phenoxo-bridged dinuclear copper (II) complexes with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity
R Loganathan, S Ramakrishnan, E Suresh, M Palaniandavar, ...
Dalton Transactions 43 (16), 6177-6194, 2014
1082014
FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer
EA Orellana, S Tenneti, L Rangasamy, LT Lyle, PS Low, AL Kasinski
Science translational medicine 9 (401), eaam9327, 2017
792017
DNA and protein binding, double-strand DNA cleavage and cytotoxicity of mixed ligand copper (II) complexes of the antibacterial drug nalidixic acid
R Loganathan, M Ganeshpandian, NSP Bhuvanesh, M Palaniandavar, ...
Journal of inorganic biochemistry 174, 1-13, 2017
752017
Mixed ligand copper (II) dicarboxylate complexes: the role of co-ligand hydrophobicity in DNA binding, double-strand DNA cleavage, protein binding and cytotoxicity
R Loganathan, S Ramakrishnan, M Ganeshpandian, NSP Bhuvanesh, ...
Dalton Transactions 44 (22), 10210-10227, 2015
602015
Synthesis, characterization and biological evaluation of novel Ru (II)–arene complexes containing intercalating ligands
S Nikolić, L Rangasamy, N Gligorijević, S Aranđelović, S Radulović, ...
Journal of Inorganic Biochemistry 160, 156-165, 2016
512016
Molecular Imaging Probes based on Matrix Metalloproteinase Inhibitors (MMPIs)
R. Loganathan, D. G. Bruno, O. Irene, C. Claire, J. M. Zapico, A. Ramos and ...
Molecules 24, 2982, 2019
42*2019
Water soluble Ru (ii)–arene complexes of the antidiabetic drug metformin: DNA and protein binding, molecular docking, cytotoxicity and apoptosis-inducing activity
D Gopalakrishnan, M Ganeshpandian, R Loganathan, NSP Bhuvanesh, ...
RSC advances 7 (60), 37706-37719, 2017
382017
Enhancing microRNA activity through increased endosomal release mediated by nigericin
EA Orellana, AM Abdelaal, L Rangasamy, S Tenneti, S Myoung, PS Low, ...
Molecular Therapy-Nucleic Acids 16, 505-518, 2019
252019
New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K+/H+ Exchange
L Rangasamy, V Chelvam, AK Kanduluru, M Srinivasarao, NA Bandara, ...
Bioconjugate chemistry 29 (4), 1047-1059, 2018
242018
Can 3D-printed bioactive glasses be the future of bone tissue engineering?
A Dukle, D Murugan, AJ Nathanael, L Rangasamy, TH Oh
Polymers 14 (8), 1627, 2022
202022
Organometallic derivatization of the nematocidal drug monepantel leads to promising antiparasitic drug candidates
J Hess, M Patra, L Rangasamy, S Konatschnig, O Blacque, A Jabbar, ...
Chemistry–A European Journal 22 (46), 16602-16612, 2016
202016
Recent developments of aptamer-based lateral flow assays for point-of-care (POC) diagnostics
A Jaisankar, S Krishnan, L Rangasamy
Analytical Biochemistry 655, 114874, 2022
172022
New dual CK2/HDAC1 inhibitors with nanomolar inhibitory activity against both enzymes
L Rangasamy, I Ortín, JM Zapico, C Coderch, A Ramos, ...
ACS Medicinal Chemistry Letters 11 (5), 713-719, 2020
142020
The use of antimicrobial biomaterials as a savior from post-operative vascular graft-related infections: A review
D Murugan, L Rangasamy
Results in Engineering 16, 100662, 2022
92022
Design and synthesis of water-soluble and potent MMP-13 inhibitors with activity in human osteosarcoma cells
JM Zapico, L Acosta, M Pastor, L Rangasamy, L Marquez-Cantudo, ...
International Journal of Molecular Sciences 22 (18), 9976, 2021
92021
Nanoparticle enhancement of natural killer (NK) cell-based immunotherapy
D Murugan, V Murugesan, B Panchapakesan, L Rangasamy
Cancers 14 (21), 5438, 2022
82022
The system can't perform the operation now. Try again later.
Articles 1–20